June 18, 1999
3 Gene Therapies for Hemophilia Are Tested
Researchers working on three tests of gene therapies for hemophilia, the disease that can result in people's bleeding to death, are attempting to get patients' own bodies to produce a cure.
The Chiron Corporation, in Emeryville, Cal., began a small trial of a form of gene therapy for hemophilia on June 1 at the University of Pittsburgh Medical Center. Researchers injected a harmless virus into a 50-year-old
This content is only for subscribers. You can gain access by purchasing a:
Print Subscription
Digital Subscription
Already have an account? Log In Now.
-
The Chronicle Review
-
Government
-
Advice
